通过生物传感器技术扩展CKD诊断:一种早期检测方法
Ganesh Pd Sahu1, Aniket Nandi1, Atanu Saha1
1Department of Pharmaceutical Chemistry and Analysis, ISF College of Pharmacy, Moga, Punjab 142001, India.
Clinica chimica acta; international journal of clinical chemistry
|January 10, 2026
概括
早期发现慢性病 (CKD) 是至关重要的. 生物传感器技术提供了一种具有成本效益和精确的解决方案,用于早期识别病,预防严重并发症并改善患者的治疗结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 生物医学工程 生物医学工程
- 诊断技术 诊断技术 诊断技术
背景情况:
- 慢性病 (CKD) 是一个重要的全球健康问题,死亡率高,由于无症状的早期阶段,往往进展不被发现.
- 先进的CKD需要昂贵的替代疗法,突出需要可访问的诊断方法.
- 目前的CKD诊断工具往往很昂贵,不易于使用,造成了及时诊断的障碍.
研究的目的:
- 系统地审查过去十年 (2015-2025) 中CKD检测方面的进展.
- 探索与CKD相关的并发症,并将传统诊断方法与现代方法进行比较.
- 突出基于生物传感器的技术在早期和准确的CKD诊断方面的潜力.
主要方法:
- 2015年至2025年间发表的综合文献综述研究.
- 对CKD并发症,传统诊断技术和新兴生物标志物的分析.
- 各种生物传感器类型的分类和评估,包括电化学,光学,光/色度和人工智能辅助的生物传感器.
主要成果:
- 生物传感器为早期CKD检测提供了一个有前途,具有成本效益和精确的替代方案.
- 最近的生物标志物和先进的生物传感器技术显示出改善诊断能力的巨大潜力.
- 人工智能辅助生物传感器代表了提高诊断准确性和效率的前沿发展.
结论:
- 通过生物传感器早期检测CKD可以显著降低患者的负担,并预防严重的并发症.
- 生物传感器技术为广泛的CKD查提供了一种用户友好且负担得起的方法.
- 对生物传感器的持续研究和开发对于打击慢性病对全球的影响至关重要.
相关概念视频
01:25Chronic Kidney Disease I: Introduction
553
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
553
01:28Chronic Kidney Disease III: Interprofessional Care
332
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
332
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
255
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
255
01:18Chronic Kidney Disease IV: Nursing Management
309
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
309
01:24Chronic Kidney Disease II: Clinical Manifestations
540
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
540
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
182
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
182